D
SAB Biotherapeutics, Inc. SABS
$2.19 $0.13956.79% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 8.10% 14.02% 19.17% -67.46% -38.15%
Total Depreciation and Amortization -33.49% -25.39% 27.96% 32.94% 36.20%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -71.96% -140.13% -124.36% 21.81% 33.76%
Change in Net Operating Assets 150.06% 133.05% -198.83% -111.09% -158.81%
Cash from Operations 17.01% 8.54% -36.52% -188.84% -132.07%
Capital Expenditure 53.49% 31.74% -71.04% -41.56% -39.33%
Sale of Property, Plant, and Equipment -98.88% -98.88% -- -100.00% --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 191.20% 177.73% -- -- --
Cash from Investing 189.13% 176.43% -7,728.66% -10,438.18% -8,326.63%
Total Debt Issued -32.57% -32.57% -32.57% -38.10% -38.10%
Total Debt Repaid -36.47% -29.40% -23.13% -2.76% 39.70%
Issuance of Common Stock -100.00% -100.00% -99.97% 676.56% 676.84%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 89.41% 44.03% -- -- --
Cash from Financing -101.21% -101.43% -101.76% 780.53% 805.29%
Foreign Exchange rate Adjustments -206.63% -1,570.59% -1,432.60% -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -243.12% -961.70% -214.81% 214.20% 207.08%